What is SystemOne?
Founded in Massachusetts in 2012, SystemOne is dedicated to developing and deploying solutions for disease surveillance and response. The company operates offices in Northampton, MA, and Johannesburg, South Africa. Its flagship disease intelligence software, Aspect®, is designed to monitor a wide array of infectious diseases, including Zika, Ebola, HIV, Malaria, and Hepatitis C, across various diagnostic devices. This focus positions SystemOne as a critical player in global public health technology and disease outbreak management.
How much funding has SystemOne raised?
SystemOne has raised a total of $5.2M across 2 funding rounds:
Series A
$5M
Debt
$150K
Series A (2018): $5M with participation from The Rise Fund
Debt (2020): $150K led by PPP
Key Investors in SystemOne
The Rise Fund
The Rise Fund is an impact investing platform focused on growth-stage, mission-driven companies aligned with UN Sustainable Development Goals. They specialize in sectors including healthcare and impact services, aiming to achieve positive social and environmental outcomes.
PPP
Public-Private Partnership
What's next for SystemOne?
The recent major strategic investment indicates a strong confidence in SystemOne's mission and technological capabilities. This influx of capital is likely to fuel further development of its Aspect® software, expand its market reach into new geographical regions, and enhance its capacity to address emerging infectious disease threats. The company's enterprise-level funding suggests a trajectory towards scaling its operations significantly, potentially through strategic partnerships or broader adoption of its disease intelligence platform by governmental and non-governmental health organizations worldwide.
See full SystemOne company page
